In a significant step toward improving access to influenza treatment, the U.S. Food and Drug Administration (FDA) has approved the first generic version of baloxavir marboxil tablets, a single-dose antiviral medicine used for the treatment and prevention of influenza. The approval comes just before the start of the 2026-27 flu season and is expected to provide patients with a more affordable treatment option.

In a significant milestone for pediatric oncology research, Indian researchers have established one of the country's largest childhood cancer survivorship cohorts, providing new insights into the long-term outcomes of children who have successfully completed cancer treatment.